Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma
Merck Sharp & Dohme LLC
Caroline Robert; Antoni Ribas; Omid Hamid; Adil Daud; Jedd D Wolchok; Anthony M Joshua; Wen-Jen Hwu; Jeffrey S Weber; Tara C Gangadhar; Richard W Joseph; Roxana Dronca; Amita Patnaik; Hassane Zarour; Richard Kefford; Peter Hersey; Jin Zhang; James Anderson; Scott J Diede; Scot Ebbinghaus; F Stephen Hodi